Articles
P21 for Cognitive Recovery After GLP-1 Discontinuation
P21, a BDNF-derived peptide, may modulate synaptic plasticity during the cognitive withdrawal window after stopping GLP-1 drugs. This article reviews
Semax vs P21 for Post-Concussion Cognitive Recovery
Semax and P21 both show preclinical TBI recovery signals, but human data differ sharply. This review compares mechanisms, intranasal delivery, and
Semax and P21 as Prophylactic Nootropics Before High-Stakes Cognitive Testing
Semax and P21 act on different timelines for cognitive resilience. This reading list covers the primary research on prophylactic use before high-stakes
Semax Nasal Spray for Post-Oral Semaglutide Cognitive Fatigue: Mechanisms Beyond BDNF
Semax nasal spray may address cognitive fatigue after oral semaglutide through mechanisms beyond BDNF, including neuroinflammation, blood flow, and
P21 vs Semax for GLP-1-Induced Cognitive Slowing: BDNF vs NGF Pathways
P21 and Semax target different neurotrophin pathways. P21 is a selective BDNF mimetic; Semax raises both BDNF and NGF. Preclinical data suggest
P21 for GLP-1-Induced Anhedonia: BDNF vs Semax
P21 raises BDNF, but no trial shows it restores reward sensitivity in non-diabetic GLP-1 users with anhedonia. Semax has slightly more animal...
Semax for Alcohol Cue Reactivity: Can This Nootropic Peptide Reduce Craving Triggers?
Exploring whether the nootropic peptide Semax could reduce alcohol cue reactivity, in light of the VA's GLP-1 trial for AUD. A look...
P21 for Cognitive Fog During GLP-1 Dose Titration
P21 is a synthetic peptide that may promote neurogenesis, but can it ease the cognitive fog some people experience when adjusting to...
P21 for Chemo Brain: Can This Nootropic Peptide Restore Cognitive Function After Cancer Treatment Amid the FDA Panel’s Peptide Review?
P21 is a nootropic peptide with animal data suggesting it could help chemo brain, but no human trials exist. We examine the...